NASDAQ: PCVX - Vaxcyte, Inc.

Rentabilidade por seis meses: -37.28%
Rendimento de dividendos: 0.00%
Setor: Healthcare

Cronograma de promoção Vaxcyte, Inc.

Agenda avançada Gráfico simples
Financial Markets by TradingView

Sobre a empresa Vaxcyte, Inc.

Vaxcyte, Inc., компания по производству биотехнологических вакцин на доклинической стадии, разрабатывает вакцины для предотвращения или лечения инфекционных заболеваний во всем мире. Ведущим кандидатом на вакцину является VAX-24, 24-валентная экспериментальная пневмококковая конъюгированная вакцина.

mais detalhes
Компания также разрабатывает VAX-XP для защиты от новых штаммов, вызывающих серьезную инвазивную пневмококковую инфекцию и устойчивость к антибиотикам; VAX-A1, конъюгированная вакцина-кандидат для защиты от подтипов Strep группы А; и VAX-PG, новый белок-кандидат в вакцину, нацеленный на гингивальную порфиромонасу. Компания ранее была известна как SutroVax, Inc. и сменила название на Vaxcyte, Inc. в мае 2020 года. Vaxcyte, Inc. была основана в 2013 году, ее штаб-квартира находится в Фостер-Сити, Калифорния.
Adicionar à lista de comparação
Adicionar à lista de observação
Adicionar ao portfólio
Adicionar aviso de preço

IPO date 2020-06-12
ISIN US92243G1085
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Сайт https://www.vaxcyte.com
Цена ао 72.76
Alteração de preço por dia: -0.6554% (73.24)
Alteração de preço por semana: -2.74% (74.81)
Alteração de preço por mês: -14.53% (85.13)
Alteração de preço em 3 meses: -17.2% (87.87)
Mudança de preço em seis meses: -37.28% (116)
Mudança de preço por ano: +5.02% (69.28)
Mudança de preço em 3 anos: +205.59% (23.81)
Mudança de preço em 5 anos: 0% (72.76)
Mudança de preço em 10 anos: 0% (72.76)
Mudança de preço desde o início do ano: -15.6% (86.21)
Todos os parâmetros

Subestimação

Nome Significado Nota
P/S 0 0
P/BV 3.02 5
P/E 12.6 8
EV/EBITDA -16.98 0
Total: 4.5

Eficiência

Nome Significado Nota
ROA, % -18.86 0
ROE, % -20.41 0
Total: 0

Dividendos

Nome Significado Nota
Div yield, % 0 0
DSI 0 0
Total: 0

Obrigação

Nome Significado Nota
Debt/EBITDA -0.1249 10
Total: 9.8

Impulso de crescimento

Nome Significado Nota
Rentabilidade Revenue, % 0 0
Rentabilidade Ebitda, % 555.4 10
Rentabilidade EPS, % 24.68 4
Total: 6.8
Mais detalhes

Instituições Volume Compartilhar, %
FMR, LLC 14213365 13.11
Blackrock Inc. 8575847 7.91
Vanguard Group Inc 8452371 7.8
RA Capital Management, L.P. 7891254 7.28
Janus Henderson Group PLC 6981376 6.44
Wellington Management Group, LLP 4431920 4.09
Capital Research Global Investors 3440107 3.17
State Street Corporation 3389528 3.13
Price (T.Rowe) Associates Inc 2677822 2.47
Geode Capital Management, LLC 1973506 1.82

ETFCompartilhar, %Rentabilidade para o ano, %Dividendos, %
Amplify Treatments Testing and Advancements ETF 3.6 10.31 1.06
Alger Mid Cap 40 ETF 2.42904 50.45 0.36073
First Trust US Equity Opportunities ETF 1.67122 39.99 0.69524
First Trust Multi-Manager Small Cap Opportunities ETF 1.36871 48.51 0.31756
Future Tech ETF 1.24715 426.34 0.8416
Principal Healthcare Innovators ETF 1.24715 618.5 0.8416
Virtus LifeSci Biotech Clinical Trials ETF 1.2312 63.04 0.33
Invesco Nasdaq Biotechnology ETF 1.22822 28.58 0.8565
iShares Russell 2000 Growth ETF 1.01624 38.04 0.6026
Direxion Daily S&P Biotech Bull 3x Shares 0.92986 4067.92 0.25924
ProShares Ultra Nasdaq Biotechnology 0.8426 51.7 0.85651
Goldman Sachs Future Health Care Equity ETF 0.73174 16.15 0.84646
iShares MSCI USA Small-Cap Min Vol Factor ETF 0.65903 18.2 1.66828
Vanguard Russell 2000 Growth ETF 0.65 23.05 0.60264
iShares Morningstar Small-Cap Growth ETF 0.48655 33.63 0.72598
iShares Morningstar Small-Cap Growth ETF 0.48655 587.89 0.72598
Schwab U.S. Small-Cap ETF 0.34293 17.47 1.51433
Harbor Disruptive Innovation ETF 0.3397 29.05 0.39896
iShares Russell 2000 ETF 0.33256 17.46 1.49082
Vanguard Russell 2000 ETF 0.33 17.16 1.48801
Fidelity Small-Mid Multifactor ETF 0.3197 32.31 1.59943
JPMorgan BetaBuilders U.S. Mid Cap Equity ETF 0.30515 21.79 1.42082
ProShares UltraPro Russell2000 0.297 89.82 1.47873
Nuveen ESG Small-Cap ETF 0.27652 13.91 1.41019
iShares ESG Aware MSCI USA Small-Cap ETF 0.27437 18.09 1.49366
iShares Morningstar Small-Cap ETF 0.24515 30.1 1.60498
iShares Morningstar Small-Cap ETF 0.24515 391.25 1.60498
BNY Mellon US Mid Cap Core Equity ETF 0.24386 30.41 1.5641
First Trust Nasdaq BuyWrite Income ETF 0.22073 7.27 0.92977
Goldman Sachs ActiveBeta US Small Cap Equity ETF 0.22055 31.36 1.41955
Vanguard U.S. Momentum Factor ETF 0.21 30.05 1.05834
Fidelity Growth Opportunities ETF 0.17367 32.75 0.48881
Fidelity MSCI Health Care Index ETF 0.15982 3 1.46057
Vanguard Extended Market ETF 0.11 24.2 1.34786
John Hancock Multifactor Mid Cap ETF 0.09197 20.65 1.52586
ProShares Hedge Replication ETF 0.08485 5.92 1.47892
Invesco FTSE RAFI US 1500 Small-Mid ETF 0.05457 17.58 1.75869
Humankind US Stock ETF 0.04792 18.81 1.99919
FlexShares Morningstar US Market Factor Tilt Index Fund 0.03748 21.94 1.69572
iShares Russell 3000 ETF 0.02473 24.83 1.43482
Schwab 1000 Index ETF 0.02471 25.15 1.42441
iShares Dow Jones U.S. ETF 0.02439 25.05 1.41797
Schwab U.S. Broad Market ETF 0.02361 24.86 1.43354
Goldman Sachs MarketBeta U.S. 1000 Equity ETF 0.02323 33 1.42661
Avantis U.S. Equity ETF 0.02289 23.04 1.59151
Vanguard Russell 3000 ETF 0.02 31.87 1.43817
Vanguard ESG U.S. Stock ETF 0.02 23.54 1.26927
John Hancock Multifactor Large Cap ETF 0.01486 21.77 1.59539
Dimensional U.S. Core Equity 2 ETF 0.01331 30.76 1.47098
Dimensional U.S. Equity ETF 0.00497 31.53 1.3557
Dimensional US Core Equity Market ETF 0.00458 30.98 1.40618
SPDR Portfolio MSCI Global Stock Market ETF 0.00282 17.99 2.19607
Dimensional US Marketwide Value ETF 0.00272 24.88 2.11042
Avantis Responsible U.S. Equity ETF 0.00108 26.78 1.45257
0.46137.791.24



Supervisor Cargo Pagamento Ano de nascimento
Mr. Andrew L. Guggenhime M.B.A. President & CFO 839.65k 1968 (57 anos)
Mr. James Wassil M.B.A., M.S. Executive VP & COO 826.3k 1969 (56 anos)
Dr. Ashish Khanna M.B.A., Ph.D. Co-Founder N/A 1972 (53 ano)
Mr. Grant E. Pickering M.B.A. Co-Founder, CEO & Director 1.1M 1968 (57 anos)
Dr. Jeff Fairman Ph.D. Co-Founder & VP of Research N/A 1964 (61 ano)
Mr. Mikhail Eydelman J.D. Senior VP, General Counsel, Chief Compliance Officer & Corporate Secretary 793.22k 1982 (43 ano)
Ms. Janet Graesser Senior Vice President of Corporate Communications & Investor Relations N/A
Ms. Elvia Cowan Senior VP of Finance & Principal Accounting Officer N/A 1973 (52 ano)
Mr. Paul W. Sauer M.B.A. Senior Vice President of Process Development & Manufacturing 608.96k 1961 (64 ano)
Ms. Whitney Jones Chief People Officer N/A

Endereço: United States, Foster City, CA , 353 Hatch Drive - abrir no Google Maps, abrir mapas Yandex
Site: https://www.vaxcyte.com